Inhibition or ablation of p21-activated kinase (PAK1) disrupts glucose homeostatic mechanisms in vivo.
about
Synapses of amphids defective (SAD-A) kinase promotes glucose-stimulated insulin secretion through activation of p21-activated kinase (PAK1) in pancreatic β-CellsSyntaxin 4 up-regulation increases efficiency of insulin release in pancreatic islets from humans with and without type 2 diabetes mellitusSignaling mechanisms of glucose-induced F-actin remodeling in pancreatic islet β cellsp21-Activated kinase (PAK) regulates cytoskeletal reorganization and directional migration in human neutrophilsp21-Activated kinase inhibitors: a patent reviewRac1 is a novel regulator of contraction-stimulated glucose uptake in skeletal muscleRac1 signaling is required for insulin-stimulated glucose uptake and is dysregulated in insulin-resistant murine and human skeletal muscleSignaling of the p21-activated kinase (PAK1) coordinates insulin-stimulated actin remodeling and glucose uptake in skeletal muscle cells.Yin-yang and Zheng: Exported from Chinese medicine.Gelidium elegans Regulates the AMPK-PRDM16-UCP-1 Pathway and Has a Synergistic Effect with Orlistat on Obesity-Associated Features in Mice Fed a High-Fat DietYES, a Src family kinase, is a proximal glucose-specific activator of cell division cycle control protein 42 (Cdc42) in pancreatic islet β cellsSystematic Synergy of Glucose and GLP-1 to Stimulate Insulin Secretion Revealed by Quantitative Phosphoproteomics.Gastrointestinal hormones/neurotransmitters and growth factors can activate P21 activated kinase 2 in pancreatic acinar cells by novel mechanismsInhibition of p21 activated kinase (PAK) reduces airway responsiveness in vivo and in vitro in murine and human airways.Syntaxin 4 Overexpression Ameliorates Effects of Aging and High-Fat Diet on Glucose Control and Extends LifespanMunc18-1 regulates first-phase insulin release by promoting granule docking to multiple syntaxin isoformsDynamin 2 regulates biphasic insulin secretion and plasma glucose homeostasisA p21-activated kinase (PAK1) signaling cascade coordinately regulates F-actin remodeling and insulin granule exocytosis in pancreatic β cells.Putting Rac1 on the path to glucose uptake.Unique catalytic activities and scaffolding of p21 activated kinase-1 in cardiovascular signalingThe p21-activated kinase (PAK1) is involved in diet-induced beta cell mass expansion and survival in mice and human islets.Interactome analysis of AMP-activated protein kinase (AMPK)-α1 and -β1 in INS-1 pancreatic beta-cells by affinity purification-mass spectrometry.Pak3 promotes cell cycle exit and differentiation of β-cells in the embryonic pancreas and is necessary to maintain glucose homeostasis in adult mice.Mouse models of PAK function.p21-Activated protein kinases and their emerging roles in glucose homeostasis.Signal transduction meets vesicle traffic: the software and hardware of GLUT4 translocation.Rho GTPases in insulin-stimulated glucose uptake.P21 activated kinases: structure, regulation, and functions.Novel approaches to drug discovery for the treatment of type 2 diabetes.Molecular mechanisms for the regulation of insulin-stimulated glucose uptake by small guanosine triphosphatases in skeletal muscle and adipocytes.The skeleton in the closet: actin cytoskeletal remodeling in β-cell function.Pdx1-Cre-driven conditional gene depletion suggests PAK4 as dispensable for mouse pancreas development.The P21-activated kinase PAK4 is implicated in fatty-acid potentiation of insulin secretion downstream of free fatty acid receptor 1.The incretin hormone GLP-1 and mechanisms underlying its secretion.Hepatic functions of GLP-1 and its based drugs: current disputes and perspectives.A critical role of the small GTPase Rac1 in Akt2-mediated GLUT4 translocation in mouse skeletal muscle.Actin dynamics regulated by the balance of neuronal Wiskott-Aldrich syndrome protein (N-WASP) and cofilin activities determines the biphasic response of glucose-induced insulin secretion.Depletion of PAK1 enhances ubiquitin-mediated survivin degradation in pancreatic β-cells.The response to PAK1 inhibitor IPA3 distinguishes between cancer cells with mutations in BRAF and Ras oncogenes.PAK1 limits the expression of the pro-apoptotic protein Bad in pancreatic islet β-cells.
P2860
Q24337361-EFE3B9DD-1B0D-4350-A0F0-6EC402BC5B3AQ24337806-63F66E7A-735F-4C41-A598-A04C7BCC77D5Q27026733-63E5460A-D4F7-4A04-BA77-7EA1985FBB9BQ27308144-84A088FA-2E6B-4328-9875-ADB66DFF7F77Q28261519-35A44A6C-6D66-475E-BE2B-D38CF90F5287Q28282342-1D4FC6BF-4AB1-42D3-8B71-C3EC698948DAQ28285890-BD51CADD-7B26-47F5-9E40-BB22A8273BC4Q28565218-1B092A53-A8A1-4D3C-87F9-FCC7FA9FC7C1Q30385603-36601FCE-9B24-4A28-B1CF-A574E036525BQ33616651-601687A9-ED1C-4FA7-BBA5-38B391927382Q33676391-35C6FAAF-45CF-48BD-898C-B65E24C84204Q33683217-7CCF4532-A0C5-4E3D-BC96-B3DF20DD9ECAQ33809148-BC6C1803-7848-455C-A357-4A73C30E8C88Q34382509-4338ADF4-6A14-4AF7-8D59-035E3AEE4F69Q36030232-90529B9E-01EA-4A63-B0A3-5A4F31BCAB0FQ36122094-EA23C85B-D24E-46E3-BC6A-BCEB0DEA7B62Q36266525-A038C9AA-07B4-40AD-9C44-736BC0D4121CQ36625877-51275253-4F56-4CC9-999F-35CC6D8F0A45Q36867619-8EE90020-4CC7-4E44-A907-4DE03EC4C7A3Q37201381-6FD5B6D6-A45D-45FB-A946-2B602F124794Q37606940-7523DBE5-D245-4DDC-81F3-32F9C69B50E1Q37636514-B6F32591-1E80-41A2-BB4C-90F2137652D0Q37670159-00F71EDC-90AF-417F-B9EA-408085BD4897Q38060731-4CEF7C37-4D80-4231-88C4-0DB3EE44445DQ38173847-2894AC22-F0F1-4DD7-9023-D178467AA1D9Q38193633-960150D0-4960-4EE8-AF2E-E442F92608C0Q38194819-D1CAF0E2-40AE-475C-A15D-D7A9EBD578E0Q38198494-71AD9132-EA43-45EA-8617-76B1BA4C803CQ38233063-CA69F18F-34A7-4017-8A1C-FEE17DCDA938Q38261084-31E95DDD-91D6-4AF7-A096-E90EDAF344C6Q38569296-AD81C816-2B49-4A2F-B7F7-1858F8C2930CQ38648337-607584F8-BE36-4202-83B7-4313C4696B4CQ38735919-1E62AB50-E1AF-4D3D-8171-F90242F66E61Q38861610-9321E103-EE42-4F46-92E8-E4E913F4AD4CQ38923365-92D6E564-4652-4D39-BA7C-1400C79FA935Q39033361-9A1B3E24-C143-4680-B59D-1B95FBEAE11EQ39124007-B3625F0D-1FAA-4B87-8F84-AF8C309DB376Q39178014-988DC47C-AF1B-4581-9863-4AB5CB01A8B2Q39301469-D78BB440-3916-4D91-8671-15ECD9040328Q40319116-D4ECC0CD-F104-43FC-A73A-1AF7D83A9424
P2860
Inhibition or ablation of p21-activated kinase (PAK1) disrupts glucose homeostatic mechanisms in vivo.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Inhibition or ablation of p21- ...... omeostatic mechanisms in vivo.
@ast
Inhibition or ablation of p21- ...... omeostatic mechanisms in vivo.
@en
type
label
Inhibition or ablation of p21- ...... omeostatic mechanisms in vivo.
@ast
Inhibition or ablation of p21- ...... omeostatic mechanisms in vivo.
@en
prefLabel
Inhibition or ablation of p21- ...... omeostatic mechanisms in vivo.
@ast
Inhibition or ablation of p21- ...... omeostatic mechanisms in vivo.
@en
P2093
P2860
P356
P1476
Inhibition or ablation of p21- ...... omeostatic mechanisms in vivo.
@en
P2093
D Wade Clapp
Debbie C Thurmond
Zhanxiang Wang
P2860
P304
41359-41367
P356
10.1074/JBC.M111.291500
P407
P577
2011-10-03T00:00:00Z